These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3523119)

  • 1. Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus.
    Van Haeften TW; Bolli GB; Dimitriadis GD; Gottesman IS; Horwitz DL; Gerich JE
    Metabolism; 1986 Jul; 35(7):649-56. PubMed ID: 3523119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin antibodies do not influence the absorption rate of subcutaneously injected insulin.
    de Meijer PH; Lutterman JA; van't Laar A
    Diabet Med; 1988 Nov; 5(8):776-81. PubMed ID: 2975571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.
    Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y
    Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin antibody binding in diabetes mellitus and factitious hypoglycemia.
    Palumbo PJ; Molnar GD; Taylor WF; Moxness KE; Tauxe WN
    Mayo Clin Proc; 1969 Oct; 44(10):725-37. PubMed ID: 5344806
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
    Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
    Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin.
    Navalesi R; Pilo A; Ferrannini E
    J Clin Invest; 1978 Jan; 61(1):197-208. PubMed ID: 338630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus.
    Bolli GB; Dimitriadis GD; Pehling GB; Baker BA; Haymond MW; Cryer PE; Gerich JE
    N Engl J Med; 1984 Jun; 310(26):1706-11. PubMed ID: 6374455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma insulin and C-peptide levels during continuous subcutaneous insulin infusion.
    Slama G; Buu KN; Tchobroutsky G; Delage A; Desplanque N
    Diabetes Care; 1979; 2(3):251-5. PubMed ID: 510116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of insulin antibodies on insulin pharmacokinetics and glucose utilization in insulin-dependent diabetic patients.
    Waldhäusl WK; Bratusch-Marrain P; Kruse V; Jensen I; Nowotny P; Vierhapper H
    Diabetes; 1985 Feb; 34(2):166-73. PubMed ID: 3881304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of insulin antibodies on postprandial plasma glucose and insulin profiles in diabetic patients without immune insulin resistance. Implications for intensive insulin regimens.
    Van Haeften TW; Heiling VJ; Gerich JE
    Diabetes; 1987 Mar; 36(3):305-9. PubMed ID: 3542653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged fasting hypoglycemia due to insulin antibodies in patient with non-insulin-dependent diabetes mellitus: effect of insulin withdrawal on insulin-antibody-binding kinetics.
    Van Haeften TW; Krom BA; Gerich JE
    Diabetes Care; 1987; 10(2):160-3. PubMed ID: 3582076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies.
    Gardner DF; Wilson HK; Podet EJ; Arakaki RF; Nell LJ; Thomas JW; Crane MM; Field JB
    J Clin Endocrinol Metab; 1986 Apr; 62(4):621-7. PubMed ID: 3512590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon.
    De Feo P; Perriello G; Ventura MM; Calcinaro F; Basta G; Lolli C; Cruciani C; Dell'Olio A; Santeusanio F; Brunetti P
    Diabetologia; 1986 Aug; 29(8):475-80. PubMed ID: 3530862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins.
    Francis AJ; Hanning I; Alberti KG
    Diabetologia; 1985 Jun; 28(6):330-4. PubMed ID: 3899818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics.
    Asplin CM; Hartog M; Goldie DJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):330-8. PubMed ID: 580135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise in insulin-dependent diabetes mellitus: the effect of continuous insulin infusion using the subcutaneous, intravenous, and intraperitoneal sites.
    Gooch BR; Abumrad NN; Robinson RP; Petrik M; Campbell D; Crofford OB
    Diabetes Care; 1983; 6(2):122-8. PubMed ID: 6343016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics.
    Gray RS; Cowan P; di Mario U; Elton RA; Clarke BF; Duncan LJ
    Br Med J (Clin Res Ed); 1985 Jun; 290(6483):1687-91. PubMed ID: 3924216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.